CombiMatrix Corporation to Release Fourth Quarter and Full Year 2014 Financial Results on February 25, 2015
February 18 2015 - 4:30PM
CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will
release its fourth quarter and full year 2014 financial results on
Wednesday, February 25, 2015. Results will be released after
the close of trading on that day.
A conference call has also been scheduled regarding CombiMatrix
Corporation's fourth quarter and full year 2014 financial results.
The presentation and Q&A session will start at 1:30 p.m. PST
(4:30 p.m. EST) on February 25, 2015.
Date: February 25, 2015 Time: 4:30 PM ET
Listen via Internet: http://investor.combimatrix.com/
Schedule this webcast into MS-Outlook calendar (click open when
prompted):
http://apps.shareholder.com/PNWOutlook/t.aspx?m=67746&k=FF9FB750
Toll-free: 1-877-407-0784 International:
1-201-689-8560
A replay of the presentation will be available following the
presentation, either via the CombiMatrix website Investor/Events
section (http://investor.combimatrix.com/events.cfm) or by dialing
1-877-870-5176 for domestic callers or 1-858-384-5517 for
direct-dial international callers. When prompted, enter playback
pin number 13601039.
About CombiMatrix Corporation
CombiMatrix Corporation provides valuable molecular diagnostic
solutions and comprehensive clinical support to foster the highest
quality in patient care. CombiMatrix specializes in miscarriage
analysis, prenatal testing and pediatric genetics, offering DNA
based testing for the detection of genetic abnormalities beyond
what can be identified through traditional methodologies.
CombiMatrix performs genetic testing utilizing a variety of
advanced cytogenomic techniques, including chromosomal microarray,
standardized and customized fluorescence in situ hybridization
("FISH") and high-resolution karyotyping. CombiMatrix is dedicated
to providing high-level clinical support for healthcare
professionals in order to help them incorporate the results of
complex genetic testing into patient-centered medical decision
making. Additional information about CombiMatrix is available at
www.combimatrix.com or by calling 1-800-710-0624.
CONTACT: Company Contact:
Mark McDonough
President & CEO, CombiMatrix Corporation
(949) 753-0624
Media Contact:
David Schull or Lena Evans
Russo Partners LLC
(212) 845-4271 or (212) 845-4262
david.schull@russopartnersllc.com
lena.evans@russopartnersllc.com
Investor Contact:
Robert Flamm, Ph.D.
Russo Partners, LLC
(212) 845-4226
robert.flamm@russopartnersllc.com
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Sep 2023 to Sep 2024